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Over the past few years, South Africa (SA) has seen a dramatic 
increase in the provision of antiretroviral therapy (ART) to persons 
living with HIV and AIDS (PLWHA). Approximately 4.4 million 
persons are receiving ART in SA (71% of persons who know their 
HIV status), and the goal is to increase this figure to 90% of all 
PLWHA by 2020.[1,2] Most PLWHA (85%) receive their medications 
through public sector facilities.[3] While this places a substantial 
burden on heath sector logistics and the health budget,[4] it has 
decreased the annual number of deaths from HIV and AIDS and 
improved the quality of life of many PLWHA.[5,6]
Many factors can affect a patient’s adherence to ART, including 
adherence self-efficacy, satisfaction with the health service provider, 
and concerns about ART. Substance use, especially alcohol use, 
also influences PLWHA’s adherence to ART.[7-9] Non-adherence to 
ART contributes to patients having a higher viral load.[10] SA has 
been identified as a country with one of the highest levels of heavy 
drinking globally.[11] A recent general population survey in one 
metropolitan area in the country, Tshwane, found that over 90% of 
the consumption of absolute alcohol there took place during heavy 
drinking occasions, defined as 8 drinks of 15 mL (12 g) for men and 
6 drinks for women.[12]
However, fairly little is known about the drinking behaviours 
of patients on ART in SA,[13] including in the Tshwane metropole 
in Gauteng Province. One cross-sectional survey, conducted in 
two HIV clinics in Tshwane, found that the Alcohol Use Disorders 
Identification Test (AUDIT)[14] scores of half the male and three-
quarters of the female drinkers were indicative of hazardous or 
harmful drinking. For a third of the participants adherence to ART 
fell below the generally acceptable level of 95%, and there was a trend 
towards a lower proportion of participants with high ART adherence 
as the quantity of alcohol use increased.[15] Research conducted in 
other parts of the country has found even higher levels of problem 
drinking in this patient population. For example, a study among HIV 
clinic attendees in Cape Town (most of whom were on ART) found 
hazardous or harmful alcohol consumption in ~9 out of 10 drinkers 
screened with the AUDIT.[16]
It has been proposed that hazardous alcohol consumption or 
binge drinking decreases overall survival of PLWHA by >3 years 
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Background. Patients on antiretroviral therapy (ART) who drink alcohol are at risk of poor medication adherence and negative health 
outcomes.
Objectives. To explore the drinking behaviour of patients on ART and assess the associations between drinking, adherence to ART and viral 
load, and in particular factors associated with binge drinking (≥6 drinks per occasion) at least monthly.
Methods. We recruited 623 HIV patients from six hospitals in the Tshwane metropole who scored positive on the Alcohol Use Disorders 
Identification Test (AUDIT-C) but were ‘non-dependent’ drinkers into a randomised controlled trial. This article reports on baseline data.
Results. Of the patients, 51% reported drinking in the past week, 60% of men and 33% of women consumed ≥6 standard drinks on a typical 
drinking day, and 19% of men and 5% of women were identified as drinking at harmful levels. Over a quarter reported having a friend or 
relative, or a doctor or other healthcare worker, express concern about their drinking or suggest that they cut down. AUDIT total scores were 
significantly negatively correlated with self-reported adherence to ART and positively correlated with viral load. Number of years on ART 
was not significantly associated with binge drinking. Persons who were employed part time (odds ratio (OR) 1.474) or were self-employed 
(OR 2.135) were more likely to binge-drink than unemployed persons. Beer drinkers (OR 1.716) were more at risk for binge drinking than 
non-beer drinkers, and persons who drank monthly or less (OR 0.053) or 2 - 4 times a month (OR 0.168) were less at risk for bingeing than 
those who drank ≥4 times per week.
Conclusions. The high volume of alcohol consumed per occasion by patients on ART, especially beer and spirits drinkers, is a concern. 
Interventions that address structural drivers of heavy drinking and target HIV patients at risk of heavy drinking are needed.
S Afr Med J 2019;109(10):784-791. https://doi.org/10.7196/SAMJ.2019.v109i10.13586
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if frequency of such consumption is once a week or more, and 
by 6.4 years with daily consumption.[17] Compared with beer and 
wine, consumption of spirits has been found to be associated with 
poor virological and immunological control in patients on ART. [18] 
Given these findings, it would be useful to identify how often 
patients on ART in SA drink, how much they drink, and what they 
are consuming. Better information is also needed regarding the 
effect of alcohol use on viral load and ART adherence. Another 
important question to investigate is whether length of time on ART 
is predictive of drinking behaviour. This point is important because 
research has shown that increased drinking, at least in women on 
ART, is associated with a decreased likelihood of adherence and viral 
suppression.[19] Frequency and quantity of alcohol consumption may 
well increase over time as patients start to feel better on ART. All this 
information may help inform treatment and management guidelines 
for patients on ART who drink in a part of the world not known for 
its moderate consumption of alcohol.[11]
In 2014, the South African Medical Research Council funded a 
randomised controlled trial to determine the efficacy of an alcohol-
focused intervention for improving adherence to ART and HIV 
treatment outcomes.[20] For the present study we used baseline data 
from this study to: (i) describe the drinking behaviour of patients 
who drink while on ART and selected health consequences; (ii) assess 
the associations between binge drinking and adherence to ART 
and viral load; (iii) assess whether patients who had been on ART 
longer were more at risk for negative drinking outcomes; and (iv) in 
particular, assess whether binge drinking among PLWHA on ART 
is associated with particular demographic characteristics, their 
frequency of drinking, and the type of alcohol consumed.
Methods
Design
The methodology of the larger study is described in detail elsewhere.[20] 
The data reported on in this article come from cross-sectional baseline 
data collected after participants were first recruited into the study.
Participants and procedures
Study participants were recruited at ART clinics in four district and two 
tertiary hospitals in Tshwane. Inclusion criteria were as follows: being 
HIV-positive; being on ART for at least 3 months; not currently being 
on treatment for tuberculosis; being ≥18 years old; being a current (past 
year) harmful/hazardous drinker (not dependent) as measured by the 
AUDIT-C[21] (AUDIT-C score ≥4 for men and ≥3 for women, but total 
AUDIT[14] score <23); being resident in/around Tshwane; not being 
enrolled in another trial; and not having extremely poor general health/
functional status (Karnofsky clinical score >50).[22,23]
Fieldworkers approached all patients seen at the ART clinics for 
eligibility screening. The patients were requested to give consent for 
both the initial screening and, if eligible, participation in the main 
study. The questionnaires were administered by trained fieldworkers 
in a private space and blood was collected by phlebotomists to assess 
viral load. Viral loads between 51 and 999 copies/mL are deemed 
detectable and viral loads >1 000 copies/mL as indicative of risk of 
treatment failure.
Participants received a grocery voucher of ZAR80 (~USD6.50) 
for their time and participation in these interviews. Ethical approval 
for the study was granted by the Ethics Committee of the South 
African Medical Research Council (ref. no. EC003-2/). Permission 
for the study was obtained from the hospitals, the health districts and 
Gauteng Province. The larger trial was registered by the Pan African 
Clinical Trials Register (ref. no. PACTR201405000815100).
In total, 3 054 PLWHA were screened across the six facilities and 
2 085 (442 men and 1 643 women) were screened out because they 
did not meet the drinking criteria for inclusion in the study. This 
means that they scored below or above the cut-off levels on the 
AUDIT-C/AUDIT. Of the 3 054 PLWA screened, 848 were found 
to be eligible for participation. Of these, 623 were finally enrolled 
at baseline. Of the patients who were eligible, 225 were not enrolled 
for a variety of reasons: not answering their phones; no longer being 
interested in participation; they had relocated; they confirmed but 
did not arrive for their appointment; or they could not get time off 
work. One patient died, one was wrongly enrolled, and one withdrew 
before completing the baseline assessment.
Assessment tools
Among the questions in the survey instrument[20] were demographic 
questions (age, gender, marital status, education, employment, 
sources of income, monthly income) and years on ART. We included 
the full 10 items of the AUDIT.[14] Particular attention was given to 
three quantity frequency questions from the AUDIT, but focusing 
on the past 3 months rather than the past 12 months so that we 
could compare the AUDIT results at the 3-month and 6-month 
follow-up points with baseline: ‘How often do you have a drink 
containing alcohol?’, ‘How many standard drinks containing alcohol 
do you have on a typical day when drinking?’, and ‘How often do you 
have 6 or more drinks on one occasion?’ In addition, we asked the 
subjects when they last consumed alcohol in the past 3 months, the 
types of alcohol usually consumed (past-month drinkers), and the 
largest number of drinks consumed on a single day. With regard to 
consequences of drinking, we focused on the last seven items from 
the AUDIT (see Table 3). The instrument also included various 
questions about adherence to ART, including the visual analogue 
scale (VAS), which assesses general levels of adherence over a 30-day 
timeframe and requires respondents to place a mark on a visual scale 
going from 0% to 100%.[24]
Data analysis
Data analysis included the provision of descriptive statistics, 
frequency tables and cross-tabulations with χ2 tests of association. 
Spearman’s rank correlation was used to assess correlations between 
total AUDIT scores and viral load, adherence to ART and years on 
ART because of the non-normality of the variables of interest. In 
order to identify factors associated with monthly or more frequent 
binge drinking (≥6 drinks on at least one occasion), variables found 
in bivariate analyses to be significantly associated at p<0.05 with 
binge drinking were entered into multiple logistic regression using 
forward stepwise selection of independent variables according to the 
Wald method. For this analysis we used Stata vce(cluster site) (Stata 
Statistical Software release 14; StataCorp, USA) in order to control 
for the cluster sampling of the six hospitals. All other analyses were 
performed using SPSS v25 (IBM, USA) and did not control for cluster 
sampling of the hospitals.
Results
Demographic characteristics and years on ART
Of the 623 study participants, over half were female (58%), had never 
married or were currently single (53%), had completed primary 
school but not grade 12 (53%), and earned <ZAR1 600 per month 
(52%) (Table 1). Their mean (standard deviation (SD)) age was 41 
(9.07) years (range 18 - 73), the rate of unemployment was high at 
42%, and they had been on ART for a mean (SD) of 7 (3.65) years 
(range 0 - 19).
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Drinking behaviour
Just over half of the study participants (51%) had consumed alcohol 
in the past week, with a high proportion reporting that they typically 
drank beer (52%), cider (47%) and wine (32%) (Table 2). Even 
though frequency of consumption was relatively low, the volumes 
consumed on a typical drinking day were very high, with 87% 
reporting consuming at least 5 drinks and 18% reporting drinking 
as many as 10 drinks per occasion. The largest number of drinks 
consumed on a single day in the past 12 months was also high, with 
37% reporting drinking a minimum of 12 drinks. More than a third 
(37%) reported at least monthly binge drinking, defined as drinking 
at least 6 drinks on one occasion in the past 6 months.
Based on their AUDIT scores, just under half of the study 
participants were defined as low-risk drinkers, while 40% could be 
categorised as hazardous drinkers and 11% as harmful drinkers. 
Significant gender differences were noted with regard to drinking 
behaviour, with men more likely to have drunk alcohol more recently 
and to drink at greater volumes. In contrast to men, who were likely 
to consume beer, spirits and homebrews, women typically consumed 
cider, wine, coolers and liqueurs. AUDIT total scores ranged from 
Table 1. Demographic characteristics of the study sample (N=623)
Age (years), mean (SD) (range) 40.8 (9.1) (18 - 73)
Gender, n (%)
Male 265 (42.5)
Female 358 (57.5)
Marital status, n (%)
Legally married 87 (14.0)
Traditionally married 86 (13.8)
Living in union with man/woman 55 (8.8)
Never married/single 328 (52.6)
Divorced 24 (3.9)
Married but separated 9 (1.4)
Widow/widower 34 (5.5)
Highest level of education, n (%)
Did not complete primary school 53 (8.5)
Completed primary school but did not complete grade 12 330 (53.0)
Completed grade 12 (high school) but no further formal education 159 (25.5)
Attended university, college, or technikon but did not graduate 31 (5.0)
Graduated from university, college, or technikon 50 (8.0)
Current employment situation, n (%)
Unemployed 264 (42.4)
Formally employed part time 110 (17.7)
Formally employed full time 185 (29.7)
Self-employed 64 (10.3)
Sources of income (non-mutually exclusive), n (%)
Work 366 (58.7)
Husband/wife/partner 216 (34.7)
Parents 95 (15.2)
Brothers or sisters 99 (15.9)
Children 45 (7.2)
Child support grant 203 (32.6)
State old-age pension 16 (2.6)
Disability grant 26 (4.2)
Foster-care grant 4 (0.6)
Other 47 (7.5)
Monthly income (ZAR) (all sources), n (%)
0 - 400 108 (17.3)
401 - 1 600 217 (34.8)
1 601 - 6 400 245 (39.3)
≥6 401 53 (8.5)
Years on ARVs, n (%)
0 - ≤4 146 (23.7)
4 - ≤7 167 (27.1)
7 - ≤9 135 (21.9)
>9 168 (27.3)
SD = standard deviation; ARVs = antiretrovirals.
787       October 2019, Vol. 109, No. 10
RESEARCH
2 to 28, with a mean (SD) of 8.88 (4.74). Greater proportions of 
women than men were classified as lower-risk drinkers according 
to the AUDIT, and greater proportions of men than women were 
categorised as hazardous and harmful drinkers (Table 2).
Selected consequences of drinking
The last seven items of the AUDIT questionnaire revealed a number 
of negative consequences associated with drinking among study 
participants (Table 3). Of particular note was the high proportion 
(16%) reporting having feelings of guilt or remorse at least monthly 
after drinking. In addition, over a quarter (26%) reported having had 
a relative or friend, or a doctor or other healthcare worker, express 
concern about their drinking during the past year or suggest that 
they cut down.
Viral load, self-reported adherence to ART, years on 
ART and association with total scores on the AUDIT
Fourteen percent of study participants showed evidence of not being 
Table 2. Drinking behaviour of drinkers on ART and AUDIT scores (N=623 except where indicated)
Total, n (%) Male, n (%) Female, n (%) p-value*
When last consumed alcohol 0.021
Past week 318 (51.0) 147 (55.7) 171 (47.6)
1 week - 1 month ago 162 (26.0) 74 (28.0) 88 (24.5)
1 - 3 months ago 88 (14.1) 27 (10.2) 61 (17.0)
3 - 6 months ago 28 (4.5) 8 (3.0) 20 (5.6)
6 months - 1 year ago 27 (4.3) 8 (3.0) 19 (5.3)
Frequency of drinking 0.000
Not in past 3 months 29 (4.7) 7 (2.6) 22 (6.1)
Monthly or less 278 (44.6) 93 (35.1) 185 (51.5)
2 - 4 times a month 247 (39.6) 116 (43.9) 131 (36.5)
2 - 3 times a week 53 (8.5) 35 (13.3) 18 (5.0)
≥4 times a week 16 (2.6) 13 (4.9) 3 (0.8)
Types of alcohol usually consumed (past-month drinkers, N=594)
Beer 308 (51.9) 216 (84.0) 92 (27.3) 0.000
Cider 276 (46.5) 62 (24.1) 214 (63.5) 0.000
Wine 188 (31.6) 56 (21.8) 132 (39.2) 0.000
Coolers 53 (8.9) 13 (5.1) 40 (11.9) 0.004
Spirits 62 (10.4) 45 (17.5) 17 (5.0) 0.000
Liqueurs 85 (14.3) 25 (9.7) 60 (17.8) 0.005
Homebrews 70 11.8) 47 (18.3) 23 (6.8) 0.000
Volume of alcohol (standard drinks consumed on typical drinking day, 
N=594)
0.000
1 - 4 77 (13.0) 23 (8.9) 54 (16.0)
5 or 6 243 (40.9) 74 (28.8) 169 (50.1)
7 - 9 168 (28.3) 95 (37.0) 73 (21.7)
≥10 106 (17.8) 65 (25.3) 41 (12.2)
Largest number of drinks consumed on a single day in past 12 months 
(N=598)
0.000
≤4 35 (5.9) 9 (3.5) 26 (7.8)
5 - 7 180 (30.6) 58 (22.7) 122 (36.6)
8 - <12 154 (26.1) 72 (28.1) 82 (24.6)
12 - 23 129 (21.9) 63 (24.6) 66 (19.8)
≥24 91 (15.4) 54 (21.1) 37 (11.1)
How often ≥6 drinks have been consumed on one occasion in past 6 
months (N=594)
0.000
Never 96 (15.9) 26 (10.1) 70 (20.8)
Less than monthly 299 (50.5) 112 (43.6) 187 (55.8)
Monthly 138(23.3) 74 (28.8) 64 (19.1)
Weekly 57 (9.6) 41 (16.0) 16 (4.8)
Daily or almost daily 4 (0.7) 4 (1.6) 0
AUDIT questionnaire total score (N=591) 0.000
Low-risk drinking (0≤AUDIT<8) 292 (49.4) 92 (35.8) 200 (59.9)
Hazardous drinking (8≤AUDIT<16) 235 (39.8) 116 (45.1) 119 (35.6)
Harmful drinking (16≤AUDIT) 64 (10.8) 49 (19.1) 15 (4.5)
ART = antiretroviral therapy; AUDIT = Alcohol Use Disorders Identification Test.
*2-tailed test.
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virally suppressed, i.e. had viral loads >1 000 copies/mL (14.5% of 
men and 13.4% of women). Just under 10% (9.6%, 13.3% of men 
and 6.8% of women) had detectable viral loads (i.e. 51 - 999 copies/
mL). Women were significantly more likely than men to be virally 
suppressed (χ2=7.29; p=0.026). Self-reported adherence to ART 
over the past month using the VAS averaged 92.4% (SD 13.49, 
range 0 - 100).
A statistically significant but small positive correlation was found 
between participants’ viral loads and their total AUDIT score 
(Spearman’s r=0.112; p=0.010). In contrast, a statistically significant 
negative correlation (Spearman’s r=–0.227) was found between VAS 
adherence scores and total scores on the AUDIT. Years on ART 
was not found to be statistically correlated with total AUDIT scores 
(Spearman’s r=–0.065; p=0.117).
Variables associated with monthly binge drinking
The following variables were found in bivariate analyses to be 
associated with monthly binge drinking: gender, i.e. being male 
(p=0.000); current employment situation, i.e. being employed 
(p=0.000); drinking beer (p=0.000), cider (p=0.002), spirits 
(p=0.000) or homebrews (p=0.034); and drinking frequency 
(p=0.000) (Table 4). The results of the multiple logistic regression 
model are presented in Table 5. Persons who were employed part 
time or were self-employed were 47% and 114% more likely to binge 
drink than unemployed persons. Beer drinkers were 72% more 
likely than non-beer drinkers to engage in monthly binge drinking. 
Persons who drank monthly or less often were 5.3% as likely to 
engage in monthly binge drinking as persons who drank ≥4 times 
per week, and persons who only drank 2 - 4 times per month were 
Table 3. Selected consequences of drinking (N=594 except where indicated)
n (%)
How often during the past year did they find they were not able to stop drinking once they started?
Never 521 (87.7)
Less than monthly 59 (9.9)
Monthly 12 (2.0)
Weekly 1 (0.2)
Daily or almost daily 1 (0.2)
How often during the past year did they fail to do what was normally expected from them as a result of drinking?
Never 475 (80.0)
Less than monthly 94 (15.8)
Monthly 22 (3.7)
Weekly 3 (0.5)
Daily or almost daily 0
How often during the past year did they need a first drink in the morning to get themselves going after a heavy  
drinking session?
Never 465 (78.3)
Less than monthly 104 (17.5)
Monthly 15 (2.5)
Weekly 9 (1.5)
Daily or almost daily 1 (0.2)
How often during the past year did they have a feeling of guilt or remorse after drinking?
Never 282 (47.5)
Less than monthly 220 (37.0)
Monthly 54 (9.1)
Weekly 24 (4.0)
Daily or almost daily 14 (2.4)
How often during the past year were they unable to remember what happened the night before because they had  
been drinking? (N=593)
Never 497 (83.8)
Less than monthly 73 (12.3)
Monthly 17 (2.9)
Weekly 4 (0.7)
Daily or almost daily 2 (0.3)
Have they or anyone else been injured as a result of their drinking?
No 508 (85.5)
Yes, but not during past year 62 (10.4)
Yes, during past year 24 (4.0)
Has a relative or friend, or a doctor or another healthcare worker, been concerned about their drinking or suggested  
they cut down?
No 344 (57.9)
Yes, but not during past year 93 (15.7)
Yes, during past year 157 (26.4)
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only 17% as likely to engage in monthly binge drinking as persons 
who drank ≥4 times per week.
Discussion
This study highlights the high level of binge drinking among non-
dependent drinkers on ART attending HIV clinics in Tshwane, 
SA. In broad terms, being employed increased the risk for ART 
patients who drink of being binge drinkers. Consumers of beer were 
significantly more likely to be binge drinkers than patients whose 
usual drink was not beer. Frequency of drinking was also related to 
Table 4. Variables associated with drinking ≥6 drinks at least monthly, bivariate analyses
χ2-value df p-value*
Gender 34.08 1 0.000
Age 1.14 3 0.769
Marital status† 1.80 1 0.180
Highest education 2.32 4 0.678
Current employment situation 18.33 3 0.000
Monthly income (all sources) 5.49 3 0.139
Type of alcohol consumed
Beer 33.29 1 0.000
Cider 9.61 1 0.002
Wine 0.00 1 0.979
Coolers 0.74 1 0.391
Spirits 21.08 1 0.000
Liqueurs 0.72 1 0.395
Homebrews 4.48 1 0.034
Frequency of drinking 100.13 3 0.000
Years on ARVs‡ 2.908 3 0.406
df = degrees of freedom; ARVs = antiretrovirals.
*2-sided test.
†Legally or traditionally married and living with spouse.
‡0 - <4, 4 - ≤7, 7 - ≤9, >9 years.
Table 5. Variables associated with drinking ≥6 drinks at least monthly, multiple logistic regression analyses†
AOR 95% CI p-value
Gender 
Male 1.389 0.783 - 2.466 0.261
Female Ref
Employment
Employed part-time 1.474 1.084 - 2.002 0.013*
Employed full-time 1.142 0.614 - 2.125 0.675
Self-employed 2.135 1.586 - 2.873 0.000*
Unemployed Ref
Beer drinker
Yes 1.716 1.098 - 2.682 0.018*
No Ref
Cider drinker
Yes 1.16 0.869 - 1.554 0.310
No Ref
Spirits drinker
Yes 2.140 0.873 - 5.248 0.097
No Ref
Homebrew drinker
Yes 1.146 0.547 - 2.398 0.718
No Ref
Frequency of drinking
Monthly or less 0.053 0.021 - 0.132 0.000*
2 - 4 times a month 0.168 0.039 - 0.723 0.017*
2 - 3 times a week 0.575 0.064 - 5.171 0.621
≥4 times a week Ref
Constant 1.795 0.531
AOR = adjusted odds ratio; CI = confidence interval.
*p<0.05.
†Variables entered in following order: drinking frequency, gender, spirits drinker, beer drinker. Employment situation, cider drinker and homebrew drinker did not enter the model (binary 
logistic regression forward stepwise (Wald)).
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risk of binge drinking, with patients who drank monthly or less or 
only 2 - 4 times a month being less at risk of bingeing than patients 
who drank ≥4  times per week. In terms of HIV treatment-related 
consequences of drinking, AUDIT total scores were significantly 
negatively correlated with self-reported adherence to ART and 
positively correlated with viral load.
Just over half of the hazardous/harmful drinkers attending ART 
clinics in Tshwane reported drinking in the past week, with beer, wine 
and cider being the most common drinks usually consumed. These 
findings mirror what was found among drinkers in a representative 
community survey of adult drinkers in Tshwane in 2014, where 49% 
reported drinking at least weekly and 46% reported beer as their 
most commonly consumed drink, followed by cider (20%), spirits 
(15%) and wine (14%).[25] Ten percent of participants in the current 
study reported weekly or more regular consumption of ≥6 drinks 
on an occasion, and 1.6% of men reported daily binge drinking 
at this level. This is of concern given that research has found that 
hazardous alcohol consumption decreases overall survival of PLWHA 
by >3 years if frequency of such consumption is once per week or 
more, and by 6.4 years with daily consumption.[17] There are various 
mechanisms through which drinking by PLWHA on ART may 
increase the risk of mortality, the most obvious being that drinking, 
and especially binge drinking, has a negative effect on compliance 
with ART regimens. HIV and alcohol consumption both modulate 
innate and adaptive immunity, and drinking by PLWHA increases 
the possibility of viral replication and the likelihood of contracting 
opportunistic infections and developing other co-morbid conditions.
[7] In addition, the medications used to treat opportunistic infections 
and other comorbid conditions interact with alcohol. Both ART 
medications and alcohol are metabolised by the liver, and alcohol-
related liver toxicity results in compromised liver function. ART 
medications may therefore not work optimally in heavy drinkers, and 
they are also at increased risk of toxicity from ART.[7,26]
The finding that AUDIT total scores were negatively correlated 
with adherence and positively correlated with viral load was to 
be expected.[7,26] Eighty-six percent of study participants (86.6% 
of women and 85.6% of men) were virally suppressed. National 
percentages in SA for viral suppression among PLWHA currently on 
ART are 88% for both genders,[2] ~2% higher than in our sample of 
PLWHA on ART who were non-dependent drinkers.
This finding raises concerns both at a patient level, given the 
effect of viral load on the infectivity of PLWHA and the generally 
acceptable level of ART adherence of 95%,[7,15,26] and at a societal 
level, given the national investment in ART in SA and the risk that 
resistance to ART will be increased.[1] It is possible that some of our 
study participants could have had high viral loads because they were 
not yet stabilised on the correct ART regimen, but given that more 
than three-quarters of the study participants had been on ART for at 
least 4 years, this is a less likely explanation for these findings than 
alcohol consumption.[26] It was, however, encouraging that years on 
ART was not found to be associated with binge drinking, suggesting 
that patients on ART do not increase their levels of drinking as their 
health starts to improve on ART.
The finding that that some groups of employed individuals on 
ART are more likely to engage in binge drinking than unemployed 
persons could be due to the fact that they had more disposable 
income. This hypothesis is supported by the trend that problematic 
drinking was higher among employed persons in the 2008 South 
African HIV, Incidence, Behaviour and Communication Survey.[27] 
The finding that beer drinkers on ART had significantly higher odds 
of binge drinking than non-drinkers of beer is also to be expected, 
given the large amounts of money spent by alcohol manufacturers on 
marketing of beer, and the particular kinds of marketing in SA that 
link consumption of beer to social and financial success.[28,29] In 2016, 
of total above-the-line advertising on alcohol in SA, 47% was spent 
on beer.[30] In addition, beer in SA is mostly sold in large containers 
holding in excess of two standard drinks, i.e. quart (750 mL) and 
660 mL returnable bottles. In 2017 South African Breweries Ltd 
introduced a 500 mL can of Carling Black Label beer sold at the same 
price as its 440 mL cans.[31] The same company in 2017 also launched 
its ‘Ama 1 litre’ Black Label bottle of beer. Increasing container size 
has had the effect of making beer more affordable, and it has also 
been argued that excise tax increases on beer in SA are differentially 
passed on to consumers according to packaging type, with a large 
proportion of the increase in excise taxes each year being carried 
by wealthier consumers of 340 mL cans of beer and the converse 
occurring for larger container sizes.[32] Moving to larger container 
sizes is likely to have the effect of encouraging the purchasing of beer 
in larger container sizes. While there is little information on the effect 
of selling beer in containers of different sizes, research has shown 
that selling wine in larger containers is associated with increased 
consumption[33] and symptoms of alcohol problems as measured by 
the CAGE questionnaire.[34]
Not only did the present study reveal high levels of binge drinking 
among many PLWHA on ART who were attending ART clinics in 
Tshwane, but ~16% of participants in the study reported feeling guilt 
or remorse after drinking and 1 in 4 indicated that during the past 12 
months a relative or friend, or a doctor or another healthcare worker, 
had been concerned about their drinking or suggested they cut down. 
However, it is possible that this concern could have been because they 
were on ART. These findings support the goals of the main study,[20] 
i.e. to test the efficacy of a blended motivational interviewing and 
problem-solving alcohol-focused intervention for hazardous and 
harmful drinking among PLWHA on ART, and the findings of an 
earlier pilot study.[13] 
Formative work undertaken as part of the roll-out of this project 
found that a third of drinkers on ART in selected HIV clinics in 
Tshwane reported hazardous drinking and 10% harmful drinking, 
and that a further 10% were possibly dependent on alcohol.[17] It 
furthermore pointed to the need for more routine screening of 
patients on ART to assess problem alcohol use.[17] The findings of 
the present substudy confirm the need to ask HIV patients on ART 
questions about binge drinking and frequency of alcohol use, and 
specifically about their use of beer. The findings regarding the link 
between alcohol use (AUDIT total scores) and adherence to ART and 
viral load require further investigation to unpack the nature of the 
link and, if needed, interventions likely to be effective in improving 
ART adherence and decreasing viral load among HIV patients on 
ART who drink. These topics will be addressed in forthcoming 
articles.
Study limitations
The present study and the data presented in this article are subject to 
a number of limitations. First, the study was confined to the Tshwane 
metropole, and as a result the findings may not be generalisable 
to other parts of SA. Second, the sampling frame was limited to 
PLWHA on ART who scored in a certain range on the AUDIT-C 
and AUDIT. Furthermore, screening of patients was not universal 
and patients who met the study criteria had to agree to take part. As 
a result, the sample may not be entirely representative of all patients 
attending these clinics. A third limitation relates to the fact that the 
study was cross-sectional, and as a result causality was not proved. It 
is possible, for example, that having a high viral load causes people 
to drink more and therefore to have a higher total AUDIT score, 
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or that not adhering to medications (perhaps because they make 
people feel worse) results in HIV patients drinking more, rather 
than the other way around. However, from a biological perspective 
these explanations are less likely than poor adherence and high viral 
load being an outcome of higher levels of alcohol consumption.[26] 
We also only looked at ‘usual’ or alcoholic beverage of choice, and 
did not take into account the fact that people often drink more than 
one beverage type. To do this would probably have required a larger 
sample size, but may have produced more nuanced findings. Finally, 
the data reported on in this study relied on self-reported drinking 
and on a single measure of adherence, the VAS.[24] Neither of these 
methods is optimal, but a biomarker for alcohol (dried blood spots 
to test for phosphatidylethanol, a biomarker of alcohol use) was 
collected as part of the study,[20] and we used three other self-report 
measures of adherence. Furthermore, although adherence was based 
on self-report, we did have viral load data, an objective outcome that 
is an indicator of adherence. In addition, supplementary research was 
undertaken to assess ART concentrations/exposure as measures of 
adherence using hair and blood. These will be reported on as part of 
further analyses of the dataset.
Conclusions
The high levels of binge drinking by ART patients in this sample 
from Tshwane, SA, especially among beer and spirits drinkers, are 
of concern given the effect of heavy drinking on ART adherence 
and viral load that may undermine the national investment in ART. 
There appears to be a ‘perfect storm’ that continues to fuel the HIV 
epidemic in SA, in that there are heavy users of alcohol who have 
poor adherence to ART, and who therefore have increased viral 
loads. The findings support goals of the larger randomised controlled 
study[20] to intervene to reduce drinking levels among patients on 
ART and the frequency of their drinking.
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